Scarica l'app Stockscreener
74.97
0.03%
0.02
Dopo l'orario di chiusura:
73.90
-1.07
-1.43%
Precedente Chiudi:
$74.95
Aprire:
$75.64
Volume 24 ore:
484.79K
Relative Volume:
0.72
Capitalizzazione di mercato:
$3.16B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-16.16
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
+6.52%
1M Prestazione:
+48.16%
6M Prestazione:
+51.79%
1 anno Prestazione:
+99.44%
Intervallo 1D:
$74.94
$76.81
Intervallo di 1 settimana:
$66.44
$76.81
Portata 52W:
$35.84
$76.81
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Nome
Tarsus Pharmaceuticals Inc
Settore
Industria
Telefono
(949) 409-9820
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Confronta TARS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
74.97 | 2.95B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-27 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-20 | Iniziato | Goldman | Neutral |
| 2023-07-18 | Iniziato | William Blair | Outperform |
| 2023-05-18 | Iniziato | Guggenheim | Buy |
| 2022-08-01 | Iniziato | Barclays | Overweight |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-23 | Iniziato | Oppenheimer | Outperform |
| 2020-11-10 | Iniziato | BofA Securities | Buy |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-11-10 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
Is Tarsus Pharmaceuticals Inc. building a consolidation baseEarnings Summary Report & Weekly High Potential Alerts - newser.com
Can a trend reversal in Tarsus Pharmaceuticals Inc. lead to recoveryBull Run & Low Drawdown Trading Strategies - newser.com
Will Tarsus Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
Tarsus Pharmaceuticals Hits Day High with 7.33% Surge in Stock Price - Markets Mojo
Can Tarsus Pharmaceuticals Inc. rally from current levels2025 Technical Overview & Stock Portfolio Risk Management - newser.com
How sentiment analysis helps forecast Tarsus Pharmaceuticals Inc.2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
Tarsus Pharmaceuticals Hits New 52-Week High of $70.58 - Markets Mojo
Tarsus Pharmaceuticals Hits New 52-Week High of $71.15 - Markets Mojo
Tarsus Pharmaceuticals (TARS) Is Up 15.1% After Xdemvy Demand and Pipeline Advances What's Changed - Sahm
Why Tarsus Pharmaceuticals Inc. stock attracts high net worth investorsJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offsWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockMarket Activity Summary & Smart Allocation Stock Tips - newser.com
Tarsus Pharmaceuticals Hits New 52-Week High of $68.00 - Markets Mojo
Tarsus Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance Indicators - Markets Mojo
Should you hold or exit Tarsus Pharmaceuticals Inc. nowWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Will Tarsus Pharmaceuticals Inc. benefit from macro trendsWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com
Tarsus Pharmaceuticals Achieves 101.95% Annual Growth, Solidifying Status as Multibagger Stock - Markets Mojo
Using data models to predict Tarsus Pharmaceuticals Inc. stock movementWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Applying big data sentiment scoring on Tarsus Pharmaceuticals Inc.Breakout Watch & Safe Capital Investment Plans - newser.com
Trend analysis for Tarsus Pharmaceuticals Inc. this weekInsider Buying & Breakout Confirmation Trade Signals - newser.com
Tarsus Pharmaceuticals (TARS): Evaluating Valuation After Xdemvy’s Strong Sales Growth and New Pipeline Announcements - Sahm
BofA Ups Price Target on Tarsus Pharmaceuticals to $85 From $80 - MarketScreener
Weiss Ratings Reaffirms "Sell (D-)" Rating for Tarsus Pharmaceuticals (NASDAQ:TARS) - MarketBeat
Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next - Yahoo Finance
Tarsus Pharmaceuticals stock hits all-time high at 69.6 USD By Investing.com - Investing.com Nigeria
Tarsus Pharmaceuticals stock hits all-time high at 69.6 USD - Investing.com
Tarsus Pharmaceuticals Hits New 52-Week High of $69.49 - Markets Mojo
Tarsus Pharmaceuticals Inc Stock Analysis and ForecastPrice Momentum Alerts & Investment Recommendations You Can Trust - earlytimes.in
Tarsus Pharmaceuticals Hits Day High with 10.89% Surge in Stock Price - Markets Mojo
Tarsus Pharmaceuticals Hits New 52-Week High of $65.97, Surges 101% - Markets Mojo
Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 52-Week HighWhat's Next? - MarketBeat
Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance
How Tarsus Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
How Tarsus Pharmaceuticals Inc. stock trades before earningsEarnings Recap Summary & Consistent Profit Trading Strategies - newser.com
Is Tarsus Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9.6% HigherTime to Buy? - MarketBeat
Tarsus Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
TARS Shares Roar Back: Explore The Surge - timothysykes.com
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):